SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-04-001585
Filing Date
2004-06-17
Accepted
2004-06-17 16:47:45
Documents
3
Group Members
ORBIMED ADVISORS LLCORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G - ORBIMED - SAMUEL ISALY sc13g_061704-transkaryotic.txt SC 13G 8668
2 JOINT FILING AGREEMENT ex1-1_061704transkaryotic.txt EX-1.1 1971
3 STATEMENT OF CONTROL PERSON ex2-1_061704transkaryotic.txt EX-2.1 748
  Complete submission text file 0000947871-04-001585.txt   13452
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47221 | Film No.: 04869183
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 787 THIRD AVE NEW YORK NY 10010 2127396400
ISALY SAMUEL D (Filed by) CIK: 0001055949 (see all company filings)